MapLight Therapeutics (MPLT) Non-Current Assets (2024 - 2026)
MapLight Therapeutics (MPLT) posted Non-Current Assets of $154.8 million for Q4 2025, up 1199.45% sequentially from $11.9 million in Q3 2025, and up 593.92% YoY from $22.3 million in Q4 2024.
Powered by 
Analysis
MapLight Therapeutics (MPLT) Non-Current Assets (2024 - 2026) Analysis & Trends
MapLight Therapeutics has reported Non-Current Assets for 2 years, with the latest figure at $154.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 5.15 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 294.93 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.96 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 18.06 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 468.65 Mn |
| 10 | MapLight Therapeutics | 642.40 Mn | 642.40 Mn | - | 49.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.56 Mn |
| Dec 31, 2025 | 154.84 Mn |
| Sep 30, 2025 | 11.92 Mn |
| Dec 31, 2024 | 22.31 Mn |